SYRS closed down 3.37 percent on Monday, June 1, 2020, on 1.75 times normal volume. SYRS | Stock Snapshot - Fidelity Jun 05, 2020 SYRS Stock Price & Charts | Syros Pharmaceuticals Description: Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology and other related markets that address gene control and cancer. $SYRS Stock Technical Analysis | Syros | SwingTradeBot.com SYRS on TradingView SYRS on StockCharts.com Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing medicines that control genes to transform the lives of patients with cancer, immune-mediated diseases, and other diseases.
OCUL - Ocular Therapeutix Inc Stock quote - CNNMoney.com Find real-time OCUL - Ocular Therapeutix Inc stock quotes, company profile, news and forecasts from CNN Business. EyePoint Pharmaceuticals: Gaining Traction (NASDAQ:EYPT ...
Document Security Systems, Inc. (NYSE: DSS) signed an exclusive Master Distributor Agreement with Advanced Cyber Security Corp. to distribute their EndpointLockV™ cyber security software BAKER BROS. ADVISORS LP Top Holdings - whalewisdom Baker Bros. Advisors is a hedge fund with 3 clients and discretionary assets under management (AUM) of $23,578,121,426 (Form ADV from 2020-03-25). Their last reported 13F filing for Q1 2020 included $16,236,233,000 in managed 13F securities and a top 10 holdings concentration of 86.32%.
ARK GENOMIC REVOLUTION MULTI SECTOR ETF (ARKG) … ark genomic revolution multi sector etf (arkg) holdings as of 06/05/2020 €company ticker cusip shares market value($) weight(%) 1 € crispr therapeutics ag crsp h17182108 1,561,097 97,193,899.22 9.34 2 € invitae corp nvta 46185l103 5,289,471 91,719,427.14 8.81 3 € illumina inc ilmn 452327109 251,982 89,229,346.02 8.57 4 € compugen ltd cgen m25722105 4,647,422 63,251,413.42 6.08 #GoldenCross $SYRS at 9.50 R8 HiLo 68% T1Y 13 buy fwdPE -5 ... Golden Cross detected for SYRS (Syros Pharmaceutical) at the close price of 9.50. Trading at a 68 % level between the 52week High (11.93) and 52week Low (4.26). The average analyst 1-year target price is 13.0 with an average buy and a score of 0.0. Golden Cross 8 % SYRS 9.50 Syros Pharmaceutical HiLo 68.3 […] #DeathCross $SYRS at 4.75 R7 HiLo 1% T1Y 14 buy 1.9 fwdPE ... Death Cross detected for SYRS (Syros Pharmaceutical) at the close price of 4.75. Trading at a 1 % level between the 52week High (11.93) and 52week Low (4.70). The average analyst 1-year target price is 14.0 with an average buy and a score of 1.9. Death Cross 7 % SYRS 4.75 Syros Pharmaceutical HiLo 0.7 […]
syrs. 23 Okt 2008 12:48. Spoštovani! Naročil sem se za 13.11.2008 tako da se takrat vidimo.Še nekaj me zanima.Ali pomeni nadražena